|
시장보고서
상품코드
2049425
구제역 백신 시장 분석 : 동물 유형별, 백신 유형별, 유통 채널별, 지역별(2026-2034년)Foot and Mouth Disease Vaccine Market Report by Animal Type, Vaccine Type, Distribution Channel, and Region 2026-2034 |
||||||
세계의 구제역(FMD) 백신 시장 규모는 2025년에 24억 1,340만 달러에 달했습니다. 향후에 대해 IMARC Group은 2026-2034년에 CAGR 6.24%로 성장하며, 2034년까지 42억 2,830만 달러에 달할 것으로 예측하고 있습니다.
구제역(FMD)은 우제류에 감염되는 국경을 넘어 전파되는 전염성 바이러스에 의해 발생합니다. 주로 버팔로, 돼지, 양, 염소 등 가축과 사슴, 들소, 들소, 낙타과 동물, 영양 등 일부 야생동물에 영향을 미친다. 구제역 바이러스(FMDV)는 O, A, C, SAT1, SAT2, SAT3, Asia 1 등 면역학적으로 서로 다른 7가지 혈청형이 있습니다. 이 바이러스성 질병은 동물에게 입술과 혀의 물집, 발열, 과도한 타액 분비, 식욕부진, 육류 및 우유 생산량 감소 등의 공통적인 증상을 보입니다. 구제역의 감염을 예방하기 위해 수산화알루미늄, 사포닌, 오일 제제를 기반으로 한 여러 백신이 사용되고 있습니다.
구제역의 높은 유병률과 더불어 동물성 제품의 국제 무역에 미치는 사회경제적 영향이 FMD 백신 시장의 성장을 주도하고 있습니다. 또한 육류 가공 산업의 확대와 유제품 소비 증가도 FMD 백신에 대한 수요를 촉진하고 있습니다. 또한 가축의 질병 없는 고품질 육류 공급에 대한 수요 증가는 시장 성장을 더욱 촉진하고 있습니다. 이와 더불어 소 사육에 대한 의무적 기준 도입으로 구제역 발생을 억제하기 위한 백신 대량 구매가 진행되고 있습니다. 또한 전 세계 정부 기관은 구제역으로부터 들소, 영양 등 멸종 위기에 처한 야생동물 종을 보호하기 위해 여러 가지 인식 개선 프로그램을 도입하고 있습니다. 글로벌화의 진전과 더불어 선진국 및 개발도상국 시장의 가축 사육두수 증가도 FMD 백신 시장의 성장을 촉진하고 있습니다. 또한 가축에게 안전한 의료 서비스를 제공하는 수의학 센터의 증가도 시장 성장에 긍정적인 영향을 미치고 있습니다.
이 보고서에서 답변하는 주요 질문
- 세계 구제역(FMD) 백신 시장의 과거 동향은 어땠을까? 향후 수년간 어떻게 변화하는가?
- COVID-19는 전 세계 구제역(FMD) 백신 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 동물 유형별 시장 구분은 어떻게 이루어지고 있는가?
- 백신 유형별 시장 구분은 어떻게 되어 있는가?
- 유통 채널별 시장 구분은 어떻게 되어 있는가?
- 이 산업의 밸류체인에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계 구제역(FMD) 백신 시장의 구조는 어떠한가? 주요 업체는 어디인가?
- 이 업계의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 분석 범위·방법
제3장 개요
제4장 서론
제5장 세계의 구제역(FMD) 백신 시장
제6장 시장 내역 : 동물 유형별
제7장 시장 내역 : 백신 유형별
제8장 시장 내역 : 유통 채널별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSA 26.06.08The global foot and mouth disease (FMD) vaccine market size reached USD 2,413.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 4,228.3 Million by 2034, exhibiting a growth rate (CAGR) of 6.24% during 2026-2034.
The foot and mouth disease (FMD) occurs due to a transboundary, contagious virus that infects cloven-hoofed animals. It primarily affects cattle, such as buffaloes, pigs, sheep, goats, etc., and a few wildlife species, including deer, bison, camelid, antelope, etc. The FMD virus (FMDV) has seven immunologically distinct serotypes, namely O, A, C, SAT1, SAT2, SAT3, and Asia 1. This viral disease exhibits common symptoms in animals, such as blisters on lips and tongue, fever, excessive salivation, anorexia, low meat and milk productivity, etc. Several vaccines, based on aluminum hydroxide , saponin, and oil formulations, are used against FMD contraction.
The high prevalence of FMD along with its socio-economic impact on the international trade of animal products is driving the FMD vaccine market. The growing meat processing industry and the increasing consumption of dairy products are also fueling the need for FMD vaccines. Additionally, the rising demand for high-grade and disease-free meat supply from livestock is further augmenting the market growth. Apart from this, the implementation of mandatory norms regarding cattle rearing is leading to the bulk purchase of vaccines to control FMD outbreaks. Furthermore, government bodies across the globe are also introducing several awareness programs for protecting endangered wildlife species, such as bison and antelope, against FMD. Rising globalization along with the growing livestock population across both developed and developing markets is also driving the market for FMD vaccines. Furthermore, the increasing presence of veterinary centers providing safe healthcare practices for livestock is also creating a positive impact on the market growth.
KEY MARKET SEGMENTATION:
Breakup by Animal Type:
- Cattle
- Pig
- Sheep and Goat
- Others
Breakup by Vaccine Type:
- Conventional Vaccines
- Oil-Based Vaccines
- Aluminum hydroxide/saponin-based Vaccines
- Emergency Vaccines
Breakup by Distribution Channel:
- Government Organizations
- Distributors/Pharmacies
- Private Vet
- Others
Breakup by Region:
- Asia Pacific
- China
- India
- Bangladesh
- Vietnam
- Korea
- Others
- Latin America
- Brazil
- Argentina
- Others
- Middle East and Africa
- Nigeria
- Ethiopia
- Iran
- Algeria
- Others
- Europe
- Turkey
- Georgia
- Armenia
COMPETITIVE LANDSCAPE :
The competitive landscape of the industry has also been examined with some of the key players being Paramount Agrovet Pvt. Ltd., Bayer AG, Biogenesis Bago, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, China Animal Husbandry Group, FGBI "Federal Center for Animal Health", Indian Immunologicals Ltd., Limor De Colombia, Merck & Co., Inc., Vecol S.A and Vetal Animal Health Products Inc.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global foot and mouth disease (FMD) vaccine market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global foot and mouth disease (FMD) vaccine market?
- What are the key regional markets?
- What is the breakup of the market based on the animal type?
- What is the breakup of the market based on the vaccine type?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global foot and mouth disease (FMD) vaccine market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Foot and Mouth Disease (FMD) Vaccine Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Animal Type
- 6.1 Cattle
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Pig
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Sheep and Goat
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Vaccine Type
- 7.1 Conventional Vaccines
- 7.1.1 Market Trends
- 7.1.2 Oil-Based Vaccines
- 7.1.2.1 Market Trends
- 7.1.2.2 Market Forecast
- 7.1.3 Aluminum hydroxide/saponin-based Vaccines
- 7.1.3.1 Market Trends
- 7.1.3.2 Market Forecast
- 7.1.4 Market Forecast
- 7.2 Emergency Vaccines
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Government Organizations
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Distributors/Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Private Vet
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 Asia Pacific
- 9.1.1 China
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 India
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.3 Bangladesh
- 9.1.3.1 Market Trends
- 9.1.3.2 Market Forecast
- 9.1.4 Vietnam
- 9.1.4.1 Market Trends
- 9.1.4.2 Market Forecast
- 9.1.5 Korea
- 9.1.5.1 Market Trends
- 9.1.5.2 Market Forecast
- 9.1.6 Others
- 9.1.6.1 Market Trends
- 9.1.6.2 Market Forecast
- 9.1.1 China
- 9.2 Latin America
- 9.2.1 Brazil
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Argentina
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 Others
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.1 Brazil
- 9.3 Middle East and Africa
- 9.3.1 Nigeria
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 Ethiopia
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 Iran
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Algeria
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Others
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.1 Nigeria
- 9.4 Europe
- 9.4.1 Turkey
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Georgia
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Armenia
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Turkey
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porter's Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Paramount Agrovet Pvt. Ltd.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Bayer AG
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Biogenesis Bago
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Boehringer Ingelheim International GmbH
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Brilliant Bio Pharma Private Limited
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 China Animal Husbandry Group
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 FGBI "Federal Center for Animal Health"
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Indian Immunologicals Ltd.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Limor de Colombia
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Merck & Co. Inc
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Vecol S.A.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Vetal Animal Health Products Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 Paramount Agrovet Pvt. Ltd.
